95%(86)82 out of 86 people found this document helpful
This preview shows page 1 - 2 out of 4 pages.
Week 11 DiscussionFor years, it was considered unethical to prescribe regular medications to children as there was no testing or dosage recommendation for these medications. After years of not being able to treat children accordingly, the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act resolved this issue by naming over 500 pediatric labeling changes (Neville, 2014). Though this was an important and life-changing event, this still remains an important public health issue for infants, children, and adolescents, because an overwhelming number of drugs still have no information in the labeling for use in pediatrics (Neville, 2014).Treating children with off-label medications is widely used in today’s practice of medicine, as there are very few studies that have been completed to substantiate further practices.The term “off-label” does not imply an improper, illegal, contraindicated, or investigational use (Neville, 2014). Instead this term is used when a child receives a medication that has not been designated for pediatric use by the Food and Drug Administration [FDA] (Bazzano, Mangione-Smith, Schonlau, Suttorp, & Brook, 2009). Albuterol is one of the medications that are used on children possibly due to the long history of having no lingering side effects. Citalopram was once used, but was also removed from children due to an increased incidence of suicide (Bazzano et al., 2009). Cisapride, once